|
| 1. | Sedative-, Hypnotic-, or Anxiolytic-Related Disorders DSM-IV-TR > Substance-Related Disorders > Introduction |
|
| 2. | Anxiolytics, Sedatives, and Hypnotics Textbook of Psychiatry > Chapter 26. Psychopharmacology |
|
| 3. | 1. Somatic Therapies APA Practice Guidelines > ASSESSING AND TREATING SUICIDAL BEHAVIORS: A Quick Reference Guide > C. Specific Treatment Modalities |
|
| 4. | 5. Antianxiety agents APA Practice Guidelines > Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors > Part A: Assessment, Treatment, and Risk Management Recommendations > IV. Specific Treatment Modalities > A. Somatic Therapies |
|
| 5. | 5. Anxiolytic agents APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments |
|
| 6. | 5. Anxiolytic and sedative-hypnotic medications APA Practice Guidelines > Practice Guideline for the Treatment of Patients With HIV/AIDS > PART B: Review and Synthesis of Available Evidence > VI. Data Regarding Psychiatric Treatments for Individuals With HIV Infection > B. Pharmacologic Treatment |
|
| 7. | b) Efficacy APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 5. Anxiolytic agents |
|
| 8. | c) Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 5. Anxiolytic agents |
|
| 9. | e) Antianxiety agents APA Practice Guidelines > Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > D. Somatic Therapies > 1. Pharmacotherapy |
|
| 10. | TABLE 267. Commonly used anxiolytic and hypnotic agents Textbook of Psychiatry > Chapter 26. Psychopharmacology > Anxiolytics, Sedatives, and Hypnotics > Overview |
|
| 11. | Anxiolytics, Sedatives, and Hypnotics Textbook of Psychiatry > Chapter 36. Treatment of Children and Adolescents > Psychopharmacology |
|
| 12. | Antianxiety Medications Psychopharmacology Patient Handouts |
|
| 13. | Antianxiety Drugs Manual of Clinical Psychopharmacology > Chapter 12. Pharmacotherapy in Special Situations > Pediatric Psychopharmacology |
|
| 14. | Chapter 6. Antianxiety Agents Manual of Clinical Psychopharmacology |
|
| 15. | Hypnotics and Anxiolytics Manual of Clinical Psychopharmacology > Chapter 12. Pharmacotherapy in Special Situations > Geriatric Psychopharmacology |
|
| 16. | Introduction Manual of Clinical Psychopharmacology > Chapter 6. Antianxiety Agents |
|
| 17. | Table 63. Other antianxiety/daytime sedative agents Manual of Clinical Psychopharmacology > Chapter 6. Antianxiety Agents > Antihistamines |
|
| 18. | Antianxiety Agents Gabbard's Treatments of Psychiatric Disorders > Chapter 31. Obsessive-Compulsive Disorder > Pharmacotherapy |
|
| 19. | Anxiolytics Gabbard's Treatments of Psychiatric Disorders > Chapter 36. Somatization Disorder and Undifferentiated Somatoform Disorder > Pharmacotherapy |
|
| 20. | Table 21. Dosing guidelines for the use of anxiolytic agents in children and adolescents Gabbard's Treatments of Psychiatric Disorders > Chapter 2. Anxiety Disorders in Children and Adolescents > Treatment Modalities > Pharmacotherapy > Benzodiazepines |
|